Michael Kays
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
- Pharmacology 36
- Antibiotics Pharmacokinetics and Efficacy 36
- Epidemiology 23
- Pneumonia and Respiratory Infections 22
- Co-authors
- Kevin M. Sowinski (12 shared papers)Hairui Liang (1 shared paper)Matthew F. Wack (8 shared papers)David W. Smith (7 shared papers)S. Christian Cheatham (12 shared papers)Gerald A. Denys (6 shared papers)Eun Kyoung Chung (9 shared papers)Daniel P. Healy (8 shared papers)
- Journals
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (11 papers)The Journal of Clinical Pharmacology (6 papers)International Journal of Antimicrobial Agents (5 papers)Annals of Pharmacotherapy (5 papers)Diagnostic Microbiology and Infectious Disease (2 papers)
- Partner nations
- United StatesSouth KoreaCanada
In The Last Decade
Michael Kays
42 papers receiving 937 citations
Peers
Comparison fields: 5 of 81
- Applied Microbiology and Biotechnology 148
- Molecular Medicine 237
- Pharmacology 722
- Analytical Chemistry 127
- Epidemiology 431
Countries citing papers authored by Michael Kays
This map shows the geographic impact of Michael Kays's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kays with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kays more than expected).
Fields of papers citing papers by Michael Kays
This network shows the impact of papers produced by Michael Kays. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kays. The network helps show where Michael Kays may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Kays, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 154 | |
| 2 | 2002 | 80 | |
| 3 | 2003 | 58 | |
| 4 | 2015 | 51 | |
| 5 | 2011 | 48 | |
| 6 | 2012 | 37 | |
| 7 | 2015 | 35 | |
| 8 | 2009 | 34 | |
| 9 | 2016 | 32 | |
| 10 | 2013 | 29 | |
| 11 | 2002 | 29 | |
| 12 | 2016 | 29 | |
| 13 | 2009 | 28 | |
| 14 | 2004 | 23 | |
| 15 | 1990 | 23 | |
| 16 | 2010 | 22 | |
| 17 | 2012 | 19 | |
| 18 | 2008 | 19 | |
| 19 | 2013 | 18 | |
| 20 | 1993 | 18 |
About Michael Kays
Michael Kays is a scholar working on Pharmacology, Epidemiology, Molecular Medicine, Infectious Diseases and Analytical Chemistry, having authored 43 papers that have together received 990 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (36 papers), Pneumonia and Respiratory Infections (22 papers), Antibiotic Resistance in Bacteria (15 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Analytical Methods in Pharmaceuticals (7 papers), Antibiotic Use and Resistance (6 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Orthopedic Infections and Treatments (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (148 citations), Molecular Medicine (237 citations), Pharmacology (722 citations), Analytical Chemistry (127 citations) and Epidemiology (431 citations). Michael Kays has collaborated with scholars based in United States, South Korea and Canada. Frequent co-authors include Kevin M. Sowinski, Hairui Liang, Matthew F. Wack, David W. Smith, S. Christian Cheatham, Gerald A. Denys, Eun Kyoung Chung, Daniel P. Healy, Katherine M. Shea and Bruce A. Mueller. Their work appears in journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, The Journal of Clinical Pharmacology, International Journal of Antimicrobial Agents, Annals of Pharmacotherapy and Diagnostic Microbiology and Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.